Skip to content
Wednesday, March 19, 2025
GLP-1 Watch
All the latest news and updates about GLP-1 Drugs
Search
Search
Privacy Policy
The Evolving Landscape of GLP-1 Drugs: Innovations, Market Trends, and Health Implications
Home
2025
March
18
Opko and Entera focus on oral care for obesity and metabolic disorders
GLP-1 News
Opko and Entera focus on oral care for obesity and metabolic disorders
March 18, 2025
Opko Health and Entera Bio have announced a partnership and licence agreement to progress the development of oral dual agonist GLP-1.
Post navigation
I’m down 2 jean sizes and falling in love with exercise. How 4 months on weight loss drugs has transformed my life. – Yahoo Life
Jim Cramer Sees General Mills (GIS) Struggling as GLP-1 Weight Loss Drugs Take Over – Yahoo Finance